Lamotrigine and valproate pharmacokinetics interactions in epileptic patients

QR Code

Lamotrigine and valproate pharmacokinetics interactions in epileptic patients

Lamotrigine (LTG, 3,5-diamino-6- (2,3-dichlorphenyl)-l,2,4-triazine) is an antiepileptic drug used mainly for partial and generalized seizures. The efficacy of LTG in treating resistant partial seizures was optimized when it was combined with valproate (VPA). The aim of this study was to investigate...

Full description

Bibliographic Details
Main Authors:	Lalic, M., Cvejic, J., Popovic, J., Bozic, K., Golocorbin-Kon, S., Al-Salami, Hani, Mikov, M.
Format:	Journal Article
Published:	Springer France 2009
Online Access:	http://hdl.handle.net/20.500.11937/8769

Similar Items

Dried blood spot: Utilising dry blood for pharmacokinetic investigations - An old method with great future for therapeutic drug monitoring
by: Golocorbin-Kon, S., et al.
Published: (2018)

Dried Blood Spot: Utilizing Dry Blood For Pharmacokinetic Investigations—An Old Method with Great Future for Therapeutic Drug Monitoring
by: Maksimovic, V., et al.
Published: (2017)

Diabetes and hypertension increase the placental and transcellular permeation of the lipophilic drug diazepam in pregnant women
by: Lalic-Popovic, M., et al.
Published: (2013)

Correlation between in vitro tests for blood brain barrier penetration with in vivo gliclazide penetration
by: Lalic-Popovic, M., et al.
Published: (2013)

Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat
by: Lalic-Popovic, M., et al.
Published: (2013)

High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect
by: Golocorbin-Kon, S., et al.
Published: (2017)

Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles
by: Pavlovic, N., et al.
Published: (2018)

Weight and fat distribution in patients taking valproate: A valproate-discordant gender-matched twin and sibling pair study
by: Petty, S., et al.
Published: (2014)

Decreased placental and transcellular permeation of cefuroxime in pregnant women with diabetes
by: Lalic-Popovic, M., et al.
Published: (2015)

The Effect of Diabetes and Hypertension on the Placental Permeation of the Hydrophilic Drug, Ranitidine
by: Lalic-Popovic, M., et al.
Published: (2016)

THE EFFECT OF BILE ACID SALT SODIUM 3ALPHA, 7ALPHA-DIHYDROXY-12-KETO-5BETA-CHOLANATE (MKC) AND PROBIOTIC PRETREATMENT ON GLICLAZIDE PERMEATION IN ILEAL TISSUES FROM HEALTHY AND DIABETIC RATS
by: Mikov, M., et al.
Published: (2014)

Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects
by: Mathavan, S., et al.
Published: (2017)

Pharmacokinetic and Drug Absorption Profiles of the Anti-Hyperglycaemic Agent Gliclazide in Oral Tissue-Targeted Microcapsules in Rats
by: Jovic, Jelena, et al.
Published: (2020)

Valproate and the risk of fracture in Rett syndrome
by: Leonard, H., et al.
Published: (2010)

Pharmacokinetic profiles among obese and non-obese patients on valproate acid in Hospital Tengku Ampuan Rahimah: a retrospective evaluation / Nurul Husna Sodri
by: Sodri, Nurul Husna
Published: (2017)

Probiotics applications in autoimmune diseases
by: Al-Salami, Hani, et al.
Published: (2012)

Lamotrigine for people with borderline personality disorder: a RCT
by: Crawford, Mike J., et al.
Published: (2018)

An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
by: Mooranian, A., et al.
Published: (2015)

A study on compliance to epileptic drug among epileptic patient attending physician clinic HUSM
by: Shaaban, Juwita
Published: (2010)

Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2012)

Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2009)

Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics
by: Mooranian, Armin, et al.
Published: (2014)

Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study
by: Mooranian, A., et al.
Published: (2015)

Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats
by: Al-Salami, Hani, et al.
Published: (2008)

Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
by: Danic, M., et al.
Published: (2018)

The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes
by: Mikov, M., et al.
Published: (2017)

Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics
by: Mikov, M., et al.
Published: (2017)

Anti-epileptic drug toxicity in children
by: Choonara, Imti
Published: (2018)

Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid
by: Mooranian, A., et al.
Published: (2018)

Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses
by: Mooranian, A., et al.
Published: (2018)

Craniofacial anthropometry, skull bone thickness and intracranial volume changes in epileptic patients
by: Shirin, Lubna
Published: (2022)

Anti-epileptic properties of terpineol extracted from Myristica fragrans Houtt. essential oil in the epileptic rat model.
by: Abdul Rahman, Mohd Amir Asyraf, et al.
Published: (2011)

The clinical effectiveness and cost effectiveness of lamotrigine for people with borderline personality disorder: a randomized, placebo-controlled trial
by: Crawford, Mike J., et al.
Published: (2018)

Application of bile acids in drug formulation and delivery
by: Stojancevic, M., et al.
Published: (2014)

Assessment of the pharmacokinetic profile of novel s-triazine derivatives and their potential use in treatment of Alzheimer's disease
by: Trifunovic, J., et al.
Published: (2017)

A study of lymphocyte subsets, activation markers and herpers viruses infection in epileptic patients in HUSM
by: Ab. Hamid, Wan Zuraida Wan
Published: (2011)

A study of lymphocyte subsets, activation markers and herpers viruses infection in epileptic patients in HUSM
by: Hamid, Wan Zuraida Wan Ab., et al.
Published: (2011)

Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation
by: Crawford, Mike J., et al.
Published: (2015)

Bile acids and probiotics could help treating diabetes
by: Calasan, J., et al.
Published: (2012)

Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment
by: Mooranian, Armin, et al.
Published: (2015)